SCHEMBL29425568

SCHEMBL29425568

CCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O

nearest known ligand 0.89

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 2/20 0.88
▸ CHAT P28329 2/20 0.84
▸ EP300 Q09472 3/20 0.83
▸ KAT5 Q92993 2/20 0.83
▸ AURKA O14965 2/20 0.83
▸ KAT2B Q92831 1/20 0.83
▸ CREBBP Q92793 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4367366 1.00 NAA50 (0.88) NAA50CHATEP300KAT5AURKA
SCHEMBL60439 1.00 NAA50 (0.88) NAA50CHATEP300KAT5AURKA
SCHEMBL22361767 1.00 NAA50 (0.88) NAA50CHATEP300KAT5AURKA
SCHEMBL28130999 1.00 NAA50 (0.88) NAA50CHATEP300KAT5AURKA
SCHEMBL4358381 1.00 NAA50 (0.88) NAA50CHATEP300KAT5AURKA
Phosphoric Acid SCHEMBL30705430 0.99 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
Methane SCHEMBL18038085 0.99 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
Methane SCHEMBL28198292 0.99 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
Acetic Acid SCHEMBL30464957 0.98 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
Acetic Acid SCHEMBL26923237 0.98 NAA50 (0.87) NAA50CHATEP300KAT5AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025104216-A1 BACTERIOPHAGE COMPOSITIONS HELMHOLTZ ZENTRUM MUENCHEN - DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2025-05-22 — — WO claimed
US-12297480-B2 Methods for producing designer esters and assessing alcohol acyltransferase specificity for ester biosynthesis UNIV TENNESSEE RES FOUND (US) 2025-05-13 — — US claimed
EP-4514951-A1 BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS Ginkgo Bioworks, Inc. (US) 2025-03-05 — — EP claimed
WO-2023212519-A1 BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS GINKGO BIOWORKS, INC. (US) 2023-11-02 — — WO claimed
US-20230340400-A1 MICROBIAL ESTER PRODUCTION AUBURN UNIVERSITY (US) 2023-10-26 — — US claimed
US-20230235368-A1 Methods for Producing Designer Esters and Assessing Alcohol Acyltransferase Specificity for Ester Biosynthesis UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2023-07-27 — — US claimed
US-20230183715-A1 SHUTTLE PLASMID REPLICABLE IN CLOSTRIDIUM AND E. COLI AND RECOMBINANT MICROORGANISM PREPARED THEREWITH AND HAVING ENHANCED PENTOSE METABOLISM AND FERMENTATION PERFORMANCE GS CALTEX CORPORATION (KR) 2023-06-15 — — US claimed
WO-2023069921-A1 RECOMBINANT THCA SYNTHASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS EPIMERON USA, INC. (US) 2023-04-27 — — WO claimed
US-20230063396-A1 GENETICALLY MODIFIED YEAST FOR THE PRODUCTION OF CANNABIGEROLIC ACID, CANNABICHROMENIC ACID AND RELATED CANNABINOIDS BAYMEDICA, INC. 2023-03-02 — — US claimed
EP-4093874-A1 GENETICALLY MODIFIED YEAST FOR THE PRODUCTION OF CANNABIGEROLIC ACID, CANNABICHROMENIC ACID AND RELATED CANNABINOIDS BayMedica, Inc. (US) 2022-11-30 — — EP claimed
WO-2022241299-A2 ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS CELLIBRE, INC. (US) 2022-11-17 — — WO claimed
CN-114525214-B Construction method and application of engineering probiotics 天津大学 2022-10-14 — — CN claimed
CN-107418938-B 10-deacetylbaccatin III 10 beta-O-acetyltransferase mutant and application thereof in catalytic synthesis of paclitaxel and analogues thereof 中国医学科学院药物研究所 2022-07-15 — — CN claimed
CN-114525214-A Construction method and application of engineering probiotics 天津大学 2022-05-24 — — CN claimed
WO-2026099447-A1 NEW BACTERIAL STRAIN THAT PRODUCES BUTYRATE AND SEVERAL INDEPENDENT FACTORS WITH ANTI-INFLAMMATORY PROPERTIES Institut National de la Santé et de la Recherche Médicale (FR) 2026-05-15 — — WO disclosed
WO-2026090486-A1 ENGINEERED CLOSTRIDIUM CELLS AND METHODS FOR USE THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2026-04-30 — — WO disclosed
CN-121065059-B Clostridium butyricum engineering strain for improving butyric acid synthesis through coenzyme A transferase pathway, construction method and application thereof 中国农业科学院北京畜牧兽医研究所 2026-04-21 — — CN disclosed
EP-3956462-A1 OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS Genomatica, Inc. (US) 2022-02-23 — — EP disclosed
WO-2022036225-A1 HUMAN MILK OLIGOSACCHARIDE COMPOSITIONS FOR USE WITH BACTERIOTHERAPIES PROLACTA BIOSCIENCE, INC. (US) 2022-02-17 — — WO disclosed
EP-3945848-A1 PROBIOTICS FOR REDUCING METHANE PRODUCTION Superbrewed Food, Inc. (US) 2022-02-09 — — EP disclosed
Send feedback